Q4FY19 results: Kilitch Drugs India registers 42.68 pct growth in operational income
Kilitch Drugs India in Q4FY19 standalone revenue from operations was at Rs 22.33 crore as against Rs 15.70 crore, recording an increase of 42.68 per cent.
Kilitch Drugs India's Board of Directors have recommended a dividend of Rs 0.50 per share of face value Rs 10, subject to shareholders approval. Photo: PTI